securities and exchange board: Aurobindo Pharma receives Sebi’s warning letter over ongoing…
on Monday said it has received a warning letter from capital markets regulator Sebi for non-disclosure of details related to an ongoing audit of one of its manufacturing units in Hyderabad and observations made by the US Food and Drug…